In the univariate analysis, the factors associated with an increased risk of CMV infection were as follows: recipient age, cold ischemia time, delayed graft function, CMV prophylaxis, thymoglobulin, mTOR inhibitor, vascular rejection, and CG carriers of the IL-18 haplotype (Table 2). The gene discussed is MTOR; the disease is cytomegalovirus infection.